ASSESSMENT TECHNOLOGIES INSTITUTE
ATI Pharmacology
Proctored Exam Test Bank
Official Practice Exam · 2026/2027 Edition
313 Verified Questions and All Correct Answers
Questions: 313 Minutes: 180 Passing Score: 80% Proctored Exam
Table of Contents
Section 1: Pharmacological Principles & Medication Administration (52 Questions)
Section 2: Central Nervous System Drugs (52 Questions)
Section 3: Cardiovascular & Renal Drugs (53 Questions)
Section 4: Respiratory & Gastrointestinal Drugs (52 Questions)
Section 5: Endocrine & Immune System Drugs (52 Questions)
Section 6: Anti-Infectives & Antineoplastics (52 Questions)
Instructions
Read each question carefully. Select the single best answer from the four options provided. A rationale
explaining the correct answer and why the top distractor is wrong follows each question. You have 180 minutes
to complete all 313 questions. A score of 80% or higher (251 of 313) is required to pass. This practice exam
follows the 2026/2027 ATI Pharmacology blueprint and is designed to mirror the format, content weighting, and
difficulty of the actual proctored examination.
ATI Pharmacology Test Bank - 2026/2027 | Passing Score: 80% | Page 1
,
,Section 1: Pharmacological Principles & Medication Administration | 2026/2027
Q1 Question 1 of 313
A 68-year-old patient with liver cirrhosis is prescribed a medication that undergoes extensive
first-pass hepatic metabolism. The nurse should anticipate that this patient will require which
dosage adjustment compared to a patient with normal hepatic function?
A. A lower dose due to reduced first-pass metabolism leading to higher bioavailability
B. A higher dose to overcome the impaired metabolism
C. The same dose because liver cirrhosis does not affect drug metabolism
D. An alternate route of administration exclusively, with no dose change
Correct Answer: A
Rationale:
In liver cirrhosis, first-pass metabolism is reduced, meaning more of the drug reaches systemic
circulation, increasing bioavailability and risk of toxicity. A lower dose is needed to prevent adverse
effects from elevated drug levels.
Q2 Question 2 of 313
A nurse is teaching a patient about the therapeutic index of a prescribed medication. The
nurse explains that a drug with a narrow therapeutic index requires which precaution?
A. The drug can be taken at any time without regard to meals
B. Close monitoring of serum drug levels is essential to avoid toxicity
C. The drug has a wide margin of safety between therapeutic and toxic doses
D. The drug rarely causes adverse effects even at high doses
Correct Answer: B
Rationale:
A narrow therapeutic index means the difference between a therapeutic dose and a toxic dose is small,
necessitating close monitoring of serum drug levels. This prevents subtherapeutic dosing and toxicity,
which can both occur with minor dose adjustments.
ATI Pharmacology Test Bank - 2026/2027 | Passing Score: 80% | Page 2
, Q3 Question 3 of 313
A patient is taking warfarin and is prescribed erythromycin for a respiratory infection. The
nurse should monitor for which potential interaction?
A. Decreased warfarin effectiveness due to enzyme induction
B. No significant interaction between these medications
C. Increased warfarin effects and bleeding risk due to CYP450 enzyme inhibition
D. Erythromycin absorption is blocked by warfarin
Correct Answer: C
Rationale:
Erythromycin inhibits CYP450 enzymes, particularly CYP3A4, which reduces warfarin metabolism and
increases its anticoagulant effect, raising bleeding risk. The INR should be closely monitored during
concurrent use.
Q4 Question 4 of 313
A nurse administers a medication intravenously to a patient. Compared to oral
administration, the IV route has which pharmacokinetic characteristic?
A. Slower onset of action due to distribution time
B. Delayed peak plasma concentration compared to oral dosing
C. Partial first-pass metabolism still occurs with IV administration
D. 100% bioavailability with immediate onset of action
Correct Answer: D
Rationale:
Intravenous administration bypasses absorption and first-pass metabolism entirely, resulting in 100%
bioavailability and immediate onset. This makes the IV route the most predictable for achieving desired
plasma concentrations rapidly.
ATI Pharmacology Test Bank - 2026/2027 | Passing Score: 80% | Page 3
ATI Pharmacology
Proctored Exam Test Bank
Official Practice Exam · 2026/2027 Edition
313 Verified Questions and All Correct Answers
Questions: 313 Minutes: 180 Passing Score: 80% Proctored Exam
Table of Contents
Section 1: Pharmacological Principles & Medication Administration (52 Questions)
Section 2: Central Nervous System Drugs (52 Questions)
Section 3: Cardiovascular & Renal Drugs (53 Questions)
Section 4: Respiratory & Gastrointestinal Drugs (52 Questions)
Section 5: Endocrine & Immune System Drugs (52 Questions)
Section 6: Anti-Infectives & Antineoplastics (52 Questions)
Instructions
Read each question carefully. Select the single best answer from the four options provided. A rationale
explaining the correct answer and why the top distractor is wrong follows each question. You have 180 minutes
to complete all 313 questions. A score of 80% or higher (251 of 313) is required to pass. This practice exam
follows the 2026/2027 ATI Pharmacology blueprint and is designed to mirror the format, content weighting, and
difficulty of the actual proctored examination.
ATI Pharmacology Test Bank - 2026/2027 | Passing Score: 80% | Page 1
,
,Section 1: Pharmacological Principles & Medication Administration | 2026/2027
Q1 Question 1 of 313
A 68-year-old patient with liver cirrhosis is prescribed a medication that undergoes extensive
first-pass hepatic metabolism. The nurse should anticipate that this patient will require which
dosage adjustment compared to a patient with normal hepatic function?
A. A lower dose due to reduced first-pass metabolism leading to higher bioavailability
B. A higher dose to overcome the impaired metabolism
C. The same dose because liver cirrhosis does not affect drug metabolism
D. An alternate route of administration exclusively, with no dose change
Correct Answer: A
Rationale:
In liver cirrhosis, first-pass metabolism is reduced, meaning more of the drug reaches systemic
circulation, increasing bioavailability and risk of toxicity. A lower dose is needed to prevent adverse
effects from elevated drug levels.
Q2 Question 2 of 313
A nurse is teaching a patient about the therapeutic index of a prescribed medication. The
nurse explains that a drug with a narrow therapeutic index requires which precaution?
A. The drug can be taken at any time without regard to meals
B. Close monitoring of serum drug levels is essential to avoid toxicity
C. The drug has a wide margin of safety between therapeutic and toxic doses
D. The drug rarely causes adverse effects even at high doses
Correct Answer: B
Rationale:
A narrow therapeutic index means the difference between a therapeutic dose and a toxic dose is small,
necessitating close monitoring of serum drug levels. This prevents subtherapeutic dosing and toxicity,
which can both occur with minor dose adjustments.
ATI Pharmacology Test Bank - 2026/2027 | Passing Score: 80% | Page 2
, Q3 Question 3 of 313
A patient is taking warfarin and is prescribed erythromycin for a respiratory infection. The
nurse should monitor for which potential interaction?
A. Decreased warfarin effectiveness due to enzyme induction
B. No significant interaction between these medications
C. Increased warfarin effects and bleeding risk due to CYP450 enzyme inhibition
D. Erythromycin absorption is blocked by warfarin
Correct Answer: C
Rationale:
Erythromycin inhibits CYP450 enzymes, particularly CYP3A4, which reduces warfarin metabolism and
increases its anticoagulant effect, raising bleeding risk. The INR should be closely monitored during
concurrent use.
Q4 Question 4 of 313
A nurse administers a medication intravenously to a patient. Compared to oral
administration, the IV route has which pharmacokinetic characteristic?
A. Slower onset of action due to distribution time
B. Delayed peak plasma concentration compared to oral dosing
C. Partial first-pass metabolism still occurs with IV administration
D. 100% bioavailability with immediate onset of action
Correct Answer: D
Rationale:
Intravenous administration bypasses absorption and first-pass metabolism entirely, resulting in 100%
bioavailability and immediate onset. This makes the IV route the most predictable for achieving desired
plasma concentrations rapidly.
ATI Pharmacology Test Bank - 2026/2027 | Passing Score: 80% | Page 3
